Recognizing Systemic (Not Peritoneal) Recurrence May Drive Survival After Optimal Resection of Colorectal Peritoneal Metastasis (CRC-PM) and the Quest for the Surrogates that Predict Outcome
- PMID: 39349913
- DOI: 10.1245/s10434-024-16295-5
Recognizing Systemic (Not Peritoneal) Recurrence May Drive Survival After Optimal Resection of Colorectal Peritoneal Metastasis (CRC-PM) and the Quest for the Surrogates that Predict Outcome
References
-
- Allievi N, Sidhom M, Samuel V, et al. Survival analysis and recurrence patterns in 555 patients with colorectal peritoneal metastases treated by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15942-1 . - DOI - PubMed
-
- Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–63. - DOI - PubMed
-
- Braam HJ, van Oudheusden TR, de Hingh IH, Nienhuijs SW, Boerma D, Wiezer MJ, van Ramshorst B. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. J Surg Oncol. 2014;109(8):841–7. https://doi.org/10.1002/jso.23597 . - DOI - PubMed
-
- Hassan S, Malcomson L, Soh YJ, Wilson MS, Clouston H, O’Dwyer ST, Kochhar R, Aziz O. Patterns and timing of recurrence following CRS and HIPEC in colorectal cancer peritoneal metastasis. Eur J Surg Oncol. 2023;49(1):202–8. https://doi.org/10.1016/j.ejso.2022.07.019 . - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
